OpenVSafe by OpenVAERS
Search V-safe

7U2-13884-77290

2 vaccinations 7 coded responses 26 check-ins 7 free-text entries 2 call cases
Sex
Male
Age at first dose
16-20
ZIP prefix
281 / NC
Registered
2021-09-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-09-05
    Registered in v-safe
  2. 2021-09-05
    Dose 1 — Pfizer-BioNTech
  3. 2021-09-05
    Health check-in — day 0, dose 1
    Feeling: Good · Headache
    Adult check-in
  4. 2021-09-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-09-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-09-08
    Survey response — days 1–6 daily, dose 1
    MedDRA: Abdominal distension — Feeling: Good · Fatigue or tiredness
    Free text: Stomach bloating
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-09-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-09-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  9. 2021-09-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-09-12
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-09-19
    Survey response — day 14, dose 1
    MedDRA: Headache, Increased appetite, Rhinorrhoea, Somnolence, Upper-airway cough syndrome — Feeling: Good · Be unable to work or attend school
    Free text: Increased appetite, increased sleepiness, and daily headaches occurring at night. Slight runny nose and post nasal drip.
    MedDRA releases: 2024-11 · check-in free text available
  12. 2021-09-28
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-10-03
    Dose 2 — Pfizer-BioNTech
    Co-administered: Flu
  14. 2021-10-03
    Health check-in — day 0, dose 2
    Feeling: Fair · Headache · Be unable to work or attend school
    Adult check-in
  15. 2021-10-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache · Be unable to work or attend school
    Adult check-in
  16. 2021-10-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Night sweats — Feeling: Good · Site: Pain, Redness, Swelling
    Free text: Unusual nighttime sweatiness.
    MedDRA releases: 2024-11 · check-in free text available
  17. 2021-10-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-10-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  19. 2021-10-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  20. 2021-10-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  21. 2021-10-10
    Survey response — day 7, dose 2
    MedDRA: Cough — Feeling: Good · Site: Redness · Headache, Fatigue or tiredness
    Free text: Coughing attacks.
    MedDRA releases: 2024-11 · check-in free text available
  22. 2021-10-17
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-10-24
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-10-31
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-11-07
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-11-14
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-01-02
    Survey response — 3 months, dose 2
    MedDRA: Chest pain, Exposure to SARS-CoV-2, Nasopharyngitis, Pain, SARS-CoV-2 test negative — Feeling: Fair
    Free text: Got a weird cold (with negative COVID test). Currently suffering from mild-moderate sharp and occasionally dull chest pains. Awaiting appointment for COVID test. Was in contact with people diagnosed with COVID.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-04-03
    Survey response — 6 months, dose 2
    MedDRA: COVID-19, Chest pain, Fatigue, Nasopharyngitis, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Chest still hurts from COVID infection and tires out easily. Many cold infections · Healthcare visit (other): Dr. Office visit.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-04-03
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  30. 2022-04-07
  31. 2022-10-03
    Survey response — 12 months, dose 2
    MedDRA: Nervous system disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Migraine disorder
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-10-03
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  33. 2022-10-04
  34. 2022-10-04
  35. 2022-10-07
  36. 2022-10-07

Vaccinations

DoseDateManufacturerCo-administered
12021-09-05Pfizer-BioNTech No
22021-10-03Pfizer-BioNTech Flu

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 9 — days 1–6 daily, dose 1

2021-09-08

Systemic reaction (other): Stomach bloating

Release 9 — day 14, dose 1

2021-09-19

Symptoms: Increased appetite, increased sleepiness, and daily headaches occurring at night. Slight runny nose and post nasal drip.

Release 10 — days 1–6 daily, dose 2

2021-10-05

Systemic reaction (other): Unusual nighttime sweatiness.

Release 10 — day 7, dose 2

2021-10-10

Systemic reaction (other): Coughing attacks.

Release 10 — 3 months, dose 2

2022-01-02

Symptoms: Got a weird cold (with negative COVID test). Currently suffering from mild-moderate sharp and occasionally dull chest pains. Awaiting appointment for COVID test. Was in contact with people diagnosed with COVID.

Release 11 — 6 months, dose 2

2022-04-03

Symptoms: Chest still hurts from COVID infection and tires out easily. Many cold infections
Healthcare visit (other): Dr. Office visit.

Release 12 — 12 months, dose 2

2022-10-03

Symptoms: Migraine disorder

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDChest pain · · ✓
SDCOVID-19 · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDIncreased appetite · · ✓
SDNasopharyngitis · · ✓
SDNervous system disorder · · ✓
SDPain · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSomnolence · · ✓
SDUpper-airway cough syndrome · · ✓
SROAbdominal distension · · ✓
SROCough · · ✓
SRONight sweats · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release